参考文献：
［1］噬血细胞综合征中国专家联盟，中华医学会儿科学分会血液学组.噬血细胞综合征诊治中国专家共识［J］.中华医学杂志，2018，98（2）：91-95.
［2］CAMPO M,BERLINER N. Hemophagocytic lymphohistiocytosis in adults［J］.J Hematol Oncol Clin North Am,2015,29（5）:915-925.
［3］RAMOS-CASALS M,BRITO-ZERON P,LOPEZ-GUILLERMO A,et al. Adult haemophagocytic syndrome［J］.Lancet,2014,383（9927）:1503-1516.
［4］ZHU LI,MENG HAITAO.Adult hemophagocytic syndrome［J］.China＆ Foreign Medical Treatment,2015（13）:191-193.
［5］TATLORGS,LONG H M,BROOKS J M,et al.The immunology of epstein-ban virus-induced-disease［J］.Annu Rev Immunol,2015,33:787-821.
［6］于程，李长钢.儿童噬血细胞综合征发病机制研究进展［J］.中国妇幼健康研究，2017，28（3）：357-360.
［7］OTROCK Z K,EBY C S.Clinical characteristics,prognostic factors,and outcomes of adult patients with hemophagocytic lymphohistiocytosis［J］.Am J Hematol,2015,90（3）:220-224.(https://www.daowen.com)
［8］HENTER J I,HORNE A,ARICóM,et al.HLH-2004:diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis［J］.Pediatr Blood Cancer,2007,48（2）:124-131.
［9］SCHRAM A M,BERLINER N.How I treat hemophagocytic lymphohistiocytosis in the adult patient［J］. Blood,2015,125 （19）:2908-2914.
［10］Lai W,Wang Y,Wang J,et al.Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease:analysis of 133 cases from a single center［J］. Hematology,2018,23（10）:810-816.
［11］Xue H,Chen C,Li W,et al. Analysis of prognostic risk factors in children with Epstein-Barr virus-associated hemophagocytic syndrome［J］. Minerva Pediatrica,2015,67（3）:251-261.
［12］ ZHOU YULAN,ZHANG R ONGYAN,LI Fei.R esearch progress on malignancyassociated hemophagocytic lymphohistiocytosis［J］.Chinese Journal of Clinical Oncology,2016,43（21）:958-961.
［13］ OTROCK Z K,GROSSMAN B J,EBY C S.Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis［J］. Int J Hematol,2018,108（5）:485-490.
（黎环 林勇 林春 潘晨）